drugset / Trial / NCT00165399
Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to see if the combination of chemotherapy drugs and drugs to suppress testosterone (hormone therapy) is effective in controlling early prostate cancer. This study will attempt to: * stop or slow the growth of disease * gain information about prostate cancer * evaluate the effectiveness and side effects of the study drug
Timeline
- Start
- 2004-03
- Primary completion
- 2005-12-31
- Completion
- 2005-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bicalutamide | Other / unclassified | — | Oral |
| Subject | Docetaxel | Small molecule | — | Intravenous |
| Subject | Goserelin | Other / unclassified | — | Other |
| Subject | estramustine | Other / unclassified | — | Oral |